Drug Profile
CG 1255
Alternative Names: CG-1255Latest Information Update: 10 May 2021
Price :
$50
*
At a glance
- Originator CircaGen Pharmaceutical
- Class Neuroprotectants; Small molecules
- Mechanism of Action Histone deacetylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurodegenerative disorders
Most Recent Events
- 05 May 2021 Errant Gene Therapeutics is now called San Rocco Therapeutics
- 27 Feb 2003 Preclinical trials in Neurodegenerative disorders in USA (unspecified route)